Facebook Ads Tout Unproven Therapy; Younger People Skip CRC Tests; Low-HER2 Tumors
(MedPage Today) -- Despite vowing to combat medical misinformation, Facebook continues to accept ads for unproven cancer treatments. (MIT Technology Review)
A federal judge denied a request by Bristol Myers Squibb (BMS) to dismiss a $6.4 billion...
Source: MedPage Today Hematology/Oncology - Category: Hematology Source Type: news